Processa Pharmaceuticals, Inc.Processa Pharmaceuticals, Inc.Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc.

No trades
See on Supercharts

Analyst rating

Based on 1 analyst giving stock ratings to PCSA in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


PCSA EPS for the last quarter is −0.77 USD despite the estimation of −0.85 USD. In the next quarter EPS is expected to reach −0.49 USD. Track more of Processa Pharmaceuticals, Inc. financials and stay on top of what is up with the company.